This post was originally published on this site.
Read Time: 6 Min Read
Tech Topics In This Article: Healthcare, AI, Atlanta startups
A rising star in the Atlanta startup scene is leveraging AI to transform healthcare.
That probably isn’t too surprising for those following technology trends in 2024. As healthcare systems look to streamline operations and improve patient outcomes, AI is increasingly stepping in to help tackle complex challenges — whether it’s predicting patient needs or improving diagnostic accuracy. And in the case of Atlanta-based GenAI Healthcare, it is helping bring personalized health insights to more people.
The startup’s AI-powered health management platform, called NexCura, is designed to give proactive care recommendations that can help “optimize wellness and prevent health issues,” the team told Hypepotamus. That can help with management of chronic conditions or help with proactive care so that patients can help users prevent health risks before they arise.
The team is made up of co-founder and CEO Ramesh Sundararajan, co-founder and CTO Kalyan Gudladana, co-founder and Chief Medical Officer Daniel Botelho, and Head of Business Development James Porter. And last month at the Atlanta Startup Awards ceremony, the local innovation scene recognized the team as the Best New Startup in town.
Following the Atlanta Startup Award win and before GenAI Healthcare’s official launch early next year, Sundararajan talked with Hypepotamus to discuss the platform’s vision, challenges in AI-driven healthcare, and what’s next for the team. His Q&A can be found here:
Question: In all the hype that surrounds AI right now (both inside and outside of healthcare), how does your technology stand out?
Answer: NexCura stands out in the crowded AI landscape by delivering real, measurable value to users. we’re not just tracking health metrics, but also empowering individuals and enterprises to proactively manage wellness through actionable insights. While others may provide raw data, NexCura transforms that data into personalized recommendations, predicting health risks and supporting real-time decisions. Imagine a world where you can report your symptoms and be given a care pathway personally catered to you that helps keep you healthy and aware of preexisting conditions. This proactive model is where healthcare needs to be—anticipating needs, not just reacting to them.
Question: When are your plans to launch NexCura?
Answer: We’re excited to launch our Beta at CES Conference in Las Vegas on January 8th and planning to launch NexCura to market by Q2 of 2025.
Question: Walk us through your go-to-market strategy. Who are you targeting as early customers?
Answer: Our go-to-market approach leverages strategic partnerships and a B2B2C model, reaching users through employers and health insurance companies. By providing NexCura as a wellness solution to their employees,members and patients, we maximize reach, longevity and employee productivity. By working with employers, we gain access to more data more quickly which helps us train and accelerate our model.
We’re targeting markets in India and the Middle East initially, where employer interest is high, and scaling from there. We’re also forming alliances with diagnostic centers and corporate health programs to create a seamless ecosystem, making NexCura accessible and beneficial across various user demographics.
Question: Tell us how the founding team got connected. Why are you the right team to solve this healthcare problem?
Answer: Our founding team connected through a shared commitment to transforming healthcare. With backgrounds spanning AI, healthcare systems, and business strategy, each of us brings unique skills to NexCura. Ramesh, Kalyan, Daniel’s expertise in technology and healthcare systems has been invaluable in developing NexCura’s AI foundation. They have been working closely with the technical and clinical team to make sure they deliver a product that fulfills NexCura’s vision.This mix of skills—paired with a vision for proactive healthcare—positions us well to address the complex needs of personalized health management. From experiencing the declining health of family and loved ones it was time to take action to solve issues before they arise.
Question: Would love to learn more about your funding journey. What investors are backing you?
Answer: To date, we’ve raised $1,000,000, with support from esteemed investors from Atlanta, Texas, California, and Dubai. Along with continued support from experienced executives in health and AI fields who believe in NexCura’s potential. Our investment funds are being used to fuel our final product development launch and post-launch go-to-market initiatives.
Question: Why is the Metro Atlanta area the right place to build something like this?
Answer: Our Co founders are very well connected with the Atlanta Startup Ecosystem which then enabled us to scale the product quickly with the help of esteemed investors and advisors. Our recent recognition as Best New Startup 2024 by Startup Atlanta underscores this alignment, positioning us at the heart of a network that’s just as committed to health transformation as we are. Atlanta provides a thriving ecosystem where technology and healthcare intersect. It’s home to leading healthcare institutions, a highly skilled workforce, and a supportive community that values innovation in health. This city gives us both the talent and the community needed to drive NexCura’s mission forward.
Question: What are your big needs as a company right now?
Answer: Our current need is to continue raising funds to scale the product and invest in business development to help close the current revenue traction of $1-$4 million dollars between 2025-2027. Currently we are in the process of raising $500,000 as a part of the bridge round and looking to raise $3 million as a part of a prized/seed round sometime between March and July of 2025.
Important links to keep up to date with NexCura and GenAI Healthcare:
Photos provided by GenAI Healthcare